PYPL
33
8
UAL
51
6
PCG
61
5
HAS
43
2
XEL
69
7
ADT
50
5
AIZ
82
9
CTAS
45
5
GE
64
6
MU
60
9
NVDA
56
4
EQT
59
5
WMB
60
4
HRL
44
3
STX
52
3
FITB
58
5
VRSK
66
-2
SO
70
4
AME
54
6
AMP
66
3
PYPL
33
8
UAL
51
6
PCG
61
5
HAS
43
2
XEL
69
7
ADT
50
5
AIZ
82
9
CTAS
45
5
GE
64
6
MU
60
9
NVDA
56
4
EQT
59
5
WMB
60
4
HRL
44
3
STX
52
3
FITB
58
5
VRSK
66
-2
SO
70
4
AME
54
6
AMP
66
3
Financhill
Back

Verona Pharma PLC 10K Form

Sell
48

VRNA
Verona Pharma PLC

Last Price:
$66.64
Seasonality Move:
-2.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02 10Q VRNA/Verona Pharma PLC Quarterly
2023-08-03 10Q VRNA/Verona Pharma PLC Quarterly
2023-05-09 10Q VRNA/Verona Pharma PLC Quarterly
2022-11-09 10Q VRNA/Verona Pharma PLC Quarterly
2022-08-09 10Q VRNA/Verona Pharma PLC Quarterly
2022-05-03 10Q VRNA/Verona Pharma PLC Quarterly

Receive VRNA News And Ratings

See the #1 stock for the next 7 days that we like better than VRNA

VRNA Financial Statistics

Sales & Book Value

Annual Sales: $42.3M
Cash Flow: $-29.4M
Price / Cash Flow: 0
Annual Sales: $2.42
Price / Book: 25.5

Profitability

EPS (TTM): -2.16000
Net Income (TTM): $-173.4M
Gross Margin: $39.7M
Return on Equity: -88.7%
Return on Assets: -45.92%

Verona Pharma PLC Earnings Forecast

Key Verona Pharma PLC Financial Ratios

  • The Gross Profit Margin over the past 14 years for VRNA is 93.89%.
  • The Selling, General & Administrative Expenses for VRNA have been equal to 354.19% of Gross Profit Margin.
  • The Research & Development expenses have been 105.43% of Revenue.
  • The Net Earning history of VRNA is -410.18% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 9 years.

Verona Pharma PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: VRNA
CUSIP: 925050
Website: veronapharma.com

Debt

Debt-to-Equity Ratio: 0.59
Current Ratio: 10.63
Quick Ratio: 10.24

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 288.89

VRNA Technical Analysis vs Fundamental Analysis

Sell
48
Verona Pharma PLC (VRNA) is a Sell

Is Verona Pharma PLC a Buy or a Sell?

  • Verona Pharma PLC stock is rated a Sell
    The current Verona Pharma PLC [VRNA] share price is $61.39. The Score for VRNA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.